Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

lncRNA MTC affects protein levels in goat skin cells, impacting hair growth.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Thermus thermophilus extract improves hair growth and scalp health in men with hair loss.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Touch dome keratinocytes in adult skin have traits of different skin cell types.

SLFC can improve scalp health and reduce sensitive scalp symptoms.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Sebaceous glands help study fatty acid transporters and binding proteins.

CTE and FPHL are different hair loss types with unique causes.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Low iron levels may be linked to hair loss in women.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

PCFCL may have unrecognized subtypes and needs more research.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.